Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BIOS

BioPlus Acquisition (BIOS) Stock Price, News & Analysis

BioPlus Acquisition logo

About BioPlus Acquisition Stock (NASDAQ:BIOS)

Advanced Chart

Key Stats

Today's Range
$10.79
$10.80
50-Day Range
$10.75
$10.84
52-Week Range
$10.05
$11.68
Volume
5,636 shs
Average Volume
122,781 shs
Market Capitalization
$209.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Receive BIOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOS Stock News Headlines

PayMate Plans to Acquire DigiAsia Bios
The stealth altcoin the financial world is underestimating
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.
See More Headlines

BIOS Stock Analysis - Frequently Asked Questions

BioPlus Acquisition (BIOS) raised $180 million in an initial public offering (IPO) on Friday, December 3rd 2021. The company issued 18,000,000 shares at $10.00 per share. Cantor acted as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioPlus Acquisition investors own include TransMedics Group (TMDX), Deciphera Pharmaceuticals (DCPH) and BioMarin Pharmaceutical (BMRN).

Company Calendar

Today
6/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
14,990,000
Market Cap
$209.10 million
Optionable
Not Optionable
Beta
0.01
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:BIOS) was last updated on 6/17/2025 by MarketBeat.com Staff
From Our Partners